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Summary Verapamil, the prototype calcium channel blocker, reversibly inhibits cell proliferation in many
normal and tumour cell lines (Schmidt et al., Cancer Res., 48, 3617, 1988). We have found that two closely
related cell lines - B16 murine melanoma cells and B10.BR normal murine melanocytes growing in culture-
behave differently in the presence of verapamil, and we are now utilising these two related cell lines to help
elucidate the molecular basis of verapamil's antiproliferative effect. In'this study, we studied cell cycle phase
distribution and c-myc gene expression in both cell lines in the absence of verapamil, during incubation with
verapamil and after the cells were washed free of verapamil. Our studies show that 100/UM verapamil rapidly
blocks DNA synthesis in melanocytes but not in B16 cells. Similarly, incubation with verapamil for 6-24h
results in a decreased c-myc signal in melanocytes, but a transient increase in c-myc expression in B16 cells.
After verapamil is washed from the cells following a 24-h incubation with drug, c-myc expression increases in
melanocytes as they begin again to proliferate, but decreases in B16 cells as they begin to die. Our disparate
results with these cell lines suggest that c-myc gene expression, regardless of its known involvement in growth
control, is not the immediate target for verapamil's inhibitory action.
The calcium channel blockers have generated much interest
in cancer research since the demonstration that at low
concentration (5-10Mm) they augment the cytotoxicity of
many standard anti-cancer agents in a variety of tumour cell
types (Tsuruo et al., 1983a,b; Yalowich & Ross, 1984, 1985;
Robinson et al., 1985; Ince et al., 1986; Merry et al., 1986).
Verapamil, the prototype calcium channel blocker, enhances
the cytotoxic effects of both vincristine and adriamycin in
vitro as well as in vivo in cells previously resistant to these
drugs (Tsuruo et al., 1981, 1983a,b). Although the precise
mechanism of this increased cytotoxic effect is not comple-
tely understood, the calcium channel blockers are thought to
act by blocking efflux of the chemotherapeutic agents from
the cell (Tsuruo et al., 1982).
At higher concentrations (10-100yM), verapamil by itself
reversibly inhibits cell growth in several human cell lines
(Schmidt et al., 1988). Protein synthesis, DNA synthesis and
RNA synthesis are all inhibited within minutes of addition
of OO M verapamil to the cells; removal of the drug by
simple washing of the cells results in a rapid resumption of
cell growth (Schmidt et al., 1988). These reversible anti-
proliferative effects of verapamil make it an ideal compound
to study cell cycle related events.
Cell growth is controlled by a cascade of events that
ultimately leads to DNA synthesis. Briefly, cell proliferation
begins when growth factors interact with the cell membrane,
sending a signal via inositol phospholipids to increase cyto-
plasmic ionised calcium by one pathway and to increase
cytoplasmic pH by another pathway (Berridge, 1984).
However, stimulation of protein kinase C by phorbol esters
(e.g. TPA) directly causes cytoplasmic alkalinisation and in
at least some cells this stimulation can by-pass the calcium
pathway (Rozengurt & Mendoza, 1985). Furthermore, the
involvement of c-onc genes in cell proliferation has been
extensively documented (Kahn & Graf, 1986).
One of the first genes linked to cell growth was the proto-
oncogene c-myc. C-myc gene expression is known to be
linked tightly to cell proliferation, increasing 10-20 fold in
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cells treated with some mitogens (Kelly et al., 1983). The c-
myc gene, which is expressed in both malignant and normal
cells, encodes a protein that is functionally involved in DNA
synthesis (Studzinski et al., 1986). This protein is believed to
directly regulate the rate at which cells divide (Cole, 1986).
The purpose of this study was to determine the effects of
verapamil on cell cycle transit and c-myc gene expression in
two closely related cell lines in order to shed further light on
the mechanisms of verapamil's antiproliferative effects.
B1O.BR normal melanocytes and B16 melanoma cells were
chosen for this study because these cells exhibited markedly
different responses to incubation with verapamil in prelimi-
nary experiments.
Methods
Cell culture
Murine melanoma cell lines B16 Fl and B16 FIO were
obtained from ATCC. The cells were grown in RPMI
medium supplemented with 10% FCS, plus penicillin, strep-
tomycin and fungizone. Melanocytes from B1O.BR mice
(Tamura et al., 1987) were kindly provided by Dr Ruth
Halaban, Yale University, New Haven, CT. These cells were
incubated in Ham's FIO medium supplemented with 15%
fetal calf serum and 48 nM TPA (12-O-tetradecanoyl-
phorbol-13-acetate), plus penicillin, streptomycin and fungi-
zone. The growth chamber was maintained at 37°C with 5%
CO2. For experiments excluding TPA, cells were incubated
in Ham's FIO medium without TPA for 48h. Cells were
used before their 20th generation. The potential for the cells
to metastasize was tested according to Fidler & Kripke
(1977). After injection of 50,000 to 100,000 cells into the tail
veins of C57BL/6 mice, the B16 FIO cells form many more
pulmonary metastases than the B16 Fl cells within 2-3
weeks. All experiments were performed at least twice.
Radioisotope incorporation
Actively growing cells (in the exponential phase) were always
used when assessing isotope incorporation, Methyl-3H-
thymidine was added to cell cultures at a final concentration
of 0.5MCiml-1. At timed intervals, cell samples were
removed after trypsinisation and added to an equal volume
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of cold 10% trichloroacetic acid. Precipitates were allowed to
form for 30min on ice before filtering through Whatman
GF/C glass filters mounted in a vacuum manifold. After
washing with cold saline solution and ethanol, the filters
were dried under a heat lamp, then counted for radioactivity
in Ready-Solv-MP (Beckman Instruments) with a scintil-
lation spectrophotometer.
Cell cycle analysis
The nuclei isolation medium (NIM) (Thornthwaite et al.,
1980) contained per litre: 10mmol phosphate buffer,
146mmol NaCl, 1.Ommol CaCl2, 0.5mmol MgSO4-7H20,
6.0ml Nonidet NP40 (Sigma) and 700 units RNase (Sigma
type lA, boiled for 10min to remove residual DNase
activity). The DNA fluorochrome propidium iodide (PI)
(Sigma) was dissolved in NIM at a concentration of
50 ugml-1. Monolayer cells (triplicates) were washed by
rinsing with phosphate buffered saline (PBS) before the
addition of NIM buffer. The nuclei were kept in NIM buffer
for at least 16h and then filtered through a 70pm nylon
mesh. Cell cycle analyses on the PI-stained nuclei were
performed on a Coulter Electronics Epics V flow cytometer
(Coulter Electronics Inc., Hialeah, FL). The instrument was
adjusted to achieve coefficients of variation for the nuclei in
the range from 3 to 5%. The relative fluorescence intensities
of 10,000 PI-stained nuclei were measured and the proportion
of nuclei in G1, S and G2-M was calculated using the Para I
data analysis program of the Epics flow cytometer.
RNA and DNA isolations and hybridisations
For RNA isolation, cells (107) were washed three times in
PBS and transferred to polypropylene tubes. The cell pellet
was resuspended in 0.5ml of extraction buffer (250mM
NaCl, 50mM Tris-hydrochloride (pH 7.4), 5mM EDTA, 1%
sodium dodecyl sulphate and 1 mgml-1 of proteinase K
(Sigma)). After incubation for 30min at 37°C the mixture
was sonicated for three 5-s bursts to shear DNA, and
extracted with a solution containing 0.5ml of phenol and
0.25ml of chloroform. The aqueous phase was extracted
again with phenol-chloroform (2:1), washed twice with
chloroform, and precipitated with ethanol. DNA was
extracted by taking up the pellet in 2M LiCl solution
containing 10mM EDTA. After centrifugation (10,000r.p.m.,
5min) the RNA pellet was suspended in H20. Total RNA
was denatured with 6% formaldehyde and 50% formamide,
heated 5min to 65°C, size fractionated on a 1% agarose gel
containing 2.2M formaldehyde and blotted onto nitro-
cellulose or nylon membranes (Hybond, Amersham) accord-
ing to Thomas (1980).
For DNA preparations, cells were added to extraction
buffer, then incubated overnight at 37°C. After phenol-
chloroform extractions, 10plIml- of RNase solution
(100jpgml-1, DNase free) was added and the mixture was
incubated for another 30min. After subsequent ammonium
acetate (3M) precipitations to remove protein, the DNA was
precipitated with ethanol. Aliquots were incubated with 3
units of restriction enzymes (Bam HI, Xba I, Xho I, Bgl II,
Sst I) per ,ug of DNA at 37°C overnight, size separated on
agarose gels, and blotted on to nitrocellulose or nylon
membranes according to Southern (1975).
Hybridisations were carried out using a nick translated
32P labelled 1,000b.p. Pst I fragment obtained from a c-myc
cDNA clone (pM c-myc 54) (Stanton et al., 1983). The
membranes were hybridised overnight at 55°C in the
presence of 10% dextran sulphate, 50% formamide, 5 x
SSC, 5 x Denhardt's solution and 100pg calf thymus DNA
ml- . Three post-hybridisation washes were carried out at
55°C with 0.75M NaCI, 0.15M Tris (pH 8), 10mM EDTA,
25mM NaPO4 (pH 6.8), 0.1% sodiumpyrophosphate, 0.1%
SDS for 1 h; 0.15M NaCl, 30mM Tris, 2mM EDTA, 25mM
NaPO4, 1 x Denhardt's solution, 0.1% sodiumpyro-
phosphate for 1 h; and 50mM NaCl, 5mM Tris, 0.4mM
EDTA, 0.1% sodiumpyrophosphate, 0.1% SDS for 1 h, as
described by DeLeon et al. (1983). The washed filters were
exposed to Kodak X-Omat X-ray film with intensifying
screens for 18-24h at -70°C. Filters were routinely
reprobed for the efficiency of 'Northern' transfer with a
probe for 18S rRNA (Bowman et al., 1981). The intensities
of the autoradiographic signals were quantitated by densito-
metric scanning.
Results
C-myc expression in normal melanocytes and melanoma cell
lines
Experiments were first performed to establish base-line c-myc
mRNA levels in continuously growing B10.BR melanocytes
and B16 melanoma cells. Because B10.BR murine melano-
cytes require the addition of TPA to their medium for
continuous growth (Tamura et al., 1987), total RNA was
extracted from cells incubated for 48h in either the presence
or absence of TPA. C-myc expression under these conditions
was compared to that obtained in B16 cells with both a high
metastatic potential (B16 FIO) and low metastatic potential
(B16 F1). The RNA was probed with a 32P-labelled
1,000b.p. PstI fragment of a c-myc clone. In one experi-
ment, the filter was double probed for both c-myc and
thymidine kinase (tk) gene expression (to confirm increased
DNA synthesis). The results of this experiment, as illustrated
by Figure 1 (upper panel, lanes 3,4) show an approximate 8-
fold increase in c-myc mRNA caused by addition of TPA.
For the analysis, the filters were reprobed for 18S rRNA as
a measure of the amount of RNA per lane (the slightly
lower amount of RNA in lane 4 has been corrected for by
densitometric analysis). Figure 1 also demonstrates that c-
myc mRNA expression in TPA-stimulated melanocytes (lane
4) is comparable to that obtained in both B16 FO0 (lane 1)
and B16 Fl melanoma cells (lane 2). Thus, actively dividing
melanocytes and melanoma cells express similar amounts of
c-myc mRNA.
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Figure 1 C-myc expression in B16 melanoma cells and BlO.BR
melanocytes. Upper panel: exponentially growing B16 Fl and
FIO cells (low and high metastatic potential) were harvested,
total RNA was isolated and 20pg each resolved on denaturing
agarose gels. BlO.BR cells were incubated in medium with or
without TPA for 48h before they were harvested, 20pg total
RNA each was resolved on denaturing agarose gels. The filters
were hybridised with 107 c.p.m. 32P nick translated c-myc cDNA
insert and a thymidine kinase (TK) gene specific probe, as
described in Materials and methods. Lower panel: the same
filters were reprobed with 32P labelled p5B for analysis of 18S
rRNA.716 K.R. HUBER et al.
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Figure 2 Restriction analysis of c-myc from Balb/c spleen and
B16 FO0 melanoma cells. DNA (20pg per lane) was digested to
completion with Bam HI (lanes 1 and 6), Xba I (lanes 2 and 7),
Xho I (lanes 3 and 8), Bgl II (lanes 4 and 9) and Sst I (lanes S
and 10). Digests were fractionated on an agarose gel, transferred
to Hybond membranes and hybridised with a 1,400 b.p. Xho I
c-myc fragment as described. The size marker is a Hind III digest
of phage Lambda DNA.
Southern analysis of c-myc gene sequences
We then assayed for possible rearrangements in the c-myc
sequences in the melanoma cells that might account for the
constitutive c-myc expression in these cells. DNA was com-
pletely digested with enzymes that have recognition sites
within the c-myc gene and in the flanking regions as
described in Methods. As can be seen in Figure 2, there are
no obvious rearrangements in the c-myc gene in the mela-
noma cells compared to normal control spleen cells. Three
separate experiments indicated that no amplification of the
c-myc gene in the B16 melanoma cells had occurred.
Effects of verapamil on cell cycle and c-myc expression
To monitor the effects of verapamil on DNA distribution
and c-myc expression, cells were incubated with verapamil
for varying periods of time. Nuclei were analysed on a flow
cytometer and RNA was isolated and assayed for c-myc
mRNA. Different effects of verapamil on melanoma cells
and normal melanocytes were obtained.
Incubation with 100 M verapamil has little effect on B16
cells, the 3H-thymidine incorporation assay shows that DNA
synthesis in B16 cells is only 10% inhibited after 3 h
(Table II). Longer incubation with 1OM verapamil tran-
siently reduces the number of cells entering from G1 into S-
phase, the cells already in S-phase continue their cell cycle
transit (Figure 3, Table I). Parallel to the induction of syn-
chronised progression through the cycle there is also a
concomitant increase in the expression of the c-myc gene
(Figure 4, 12h-lane). A high proportion of the cells in this
line continues to traverse the cell cycle even after 24h of
incubation with lOOiM verapamil as evidenced by the con-
siderable percentage of cells in S-phase (Table I, 24h incuba-
tion with verapamil). However, drastic changes are seen once
the drug is washed from the cells. Approximately 12h after
removal of verapamil the B16 cells start to produce melanin
and die. Increased cell death is also reflected by the high
amount of fluorescent material in front of the GI peak in
Table I Effects of verapamil on cell cycle phase distribution in
BlO.BR normal melanocytes and B16FIO melanoma cells
Cell % of cells % of cells % of cells
line Treatment in Go-G1 in S in G2-M
B16 FIO Control 48.3+2.8a 39.5+5.6 12.1+2.8
6h VP 44.5+1.6 36.4+0.9 19.1+1.7
12h VP 65.1+1.4 23.5+1.2 11.4+0.7
24h VP 66.4+3.4 24.8+2.3 8.8+2.3
Release 56.2+3.8 30.4+5.8 13.4+2.5
BIO.BR Control 71.9+3.6 20.2+4.9 7.9+ 1.5
6h VP 74.8+2.5 11.3+1.6 13.9+3.7
12h VP 75.1+1.9 12.9+2.3 12.0+3.0
24h VP 79.9+1.1 8.1+2.7 11.9+1.8
Release 68.1+1.2 17.3+1.0 14.5+1.0
aMean+s.d. of results obtained independently for three replicate
cultures of one representative experiment. Cells were incubated 24h
with verapamil, drug was washed off, and the cells were harvested
another 24h later. Verapamil (100 M) was added to exponentially
growing cells. At the times indicated, cells were harvested and phase
distributions were estimated by computer analysis of DNA histo-
grams obtained by flow cytometry of propidium iodide-stained
nuclei.
Table II Sensitivity of BlO.BR normal melano-
cytes and B16FO0 melanoma cells to verapamil
% inhibition of[3H]-Thy
incorporation
/1M verapamil BIO.BR B16
25 42+7a 0
50 59+6 11+7
75 66+2 12+10
100 76+2 10+9
200 92+3 38+5
aMean+s.d. of one representative experiment
(n=5). Exponentially growing cells were incubated
for 3h with varying concentrations of verapamil.
3H-thymidine (1 pCi ml-1) was added and incor-
porated nucleotide measured as described in the
text.
the DNA histogram (Figure 3, VP release) (indicating that
the cells have released nucleic acids while they deteriorated)
and by about 50% lower c-myc mRNA levels (Figure 4).
Apparently, addition of verapamil induces differentiation in
these cells.
By contrast, cell growth in B10.BR normal melanocytes is
blocked rapidly and reversibly by 100l M verapamil as
occurs also in other cell lines tested previously (Schmidt et
al., 1988). DNA synthesis is reduced by 76% within 3h of
adding 100Mm verapamil (Table II). The cell cycle phase
analyses data (Figure 3 and Table I) show that the cells do
not enter into S-phase in the presence of verapamil. Cells
already in S-phase, however, proceed through the DNA
synthesis phase. Concomitantly, the c-myc signal is decreased
(Figure 4). After the B10.BR cells are washed free of
verapamil, they rapidly resume growth as also depicted by
the DNA histogram (Figure 3) and increased c-myc mRNA
levels (Figure 4).
In summary, verapamil has different effects on the two cell
lines studied. The B16 melanoma cells seem to be induced to
a differentiation pathway, whereas cell growth of the B10.BR
melanocytes is blocked rapidly and reversibly. C-myc mRNA
levels parallel the distribution of cells in the cell cycle
indicating that changes in c-myc gene expression are secon-
dary effects of the calcium channel blocker.
Discussion
Our work shows that two closely related cell lines are
affected differently by verapamil. The proliferation of
normal B1O.BR melanocytes is stopped rapidly and rever-VERAPAMIL AND c-myc EXPRESSION 717
B16 F10
Channel number
beyond protein kinase C in the signal cascade that ultimately
leads to DNA synthesis.
By contrast, melanoma cells continue to proliferate in the
presence of 100l M verapamil. This was the first cell line
tested so far in this laboratory that continued to proliferate
in the presence of verapamil without having been selected for
resistance. However, addition of verapamil seems to induce a
differentiation pathway because these cells start to produce
melanin and die after verapamil is removed. It remains to be
established whether this induction of differentiation can be
exploited for in vivo treatment.
Since c-myc gene expression is known to be tightly linked
to cell proliferation we were interested in the effects of
250 verapamil on the expression of this gene. This linkage is not
completely straightforward, however, because in some in
vitro differentiation model systems c-myc expression is
B10. BR
Channel number
Figure 3 DNA histograms of B10.BR normal r
B16 F10 melanoma cells: effect of verapamil on c
After various periods of incubation with 100uM
were harvested and DNA histograms of 10
iodide-stained nuclei were obtained by flow cytoi
were translocated to channel 25 for the B10.B
channel 50 (to indicate polyploidity) for the B16
were analysed and graphically summarised.
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Figure 4 C-myc expression in B10.BR normal r
B16 F10 melanoma cells: effect of verapamil
expression. Upper panels: exponentially growing
bated with 100lM verapamil for the time indic;
harvested, total RNA was isolated and 20pg e'
denaturing agarose gels. The filters were I
107 c.p.m. 32P nick translated (> 108 c.p.m. per p
insert as described in the text. Lower panels:
were reprobed with 32P-labelled p5B for analysi
The intensities of the signals are: B16FIO: conti
VP=145%, 24h VP=92%, VP-release=4
control=100%, 6h VP=37%, 12h VP=44%,
VP-release =58%.
sibly by 100pM verapamil. The results wil
parallel our recent findings on a variety of bi
lines and normal fibroblasts (Schmidt et
contrast to those cells, however, the B10.BR
continuously incubated with the mitogen
seems that verapamil induces the same re,
incubated with and without this mitogen. Ou
that verapamil exerts its antiproliferative effe(
slightly increased following the induction of differentiation
(Curran & Morgan, 1985; Lachman & Skoultchi, 1984), and
myc protein levels can stay unchanged while myc mRNA
levels are decreased (Wingrove et al., 1988).
Our results show that c-myc mRNA levels parallel the
effects of verapamil, decreasing in the melanocytes while the
cells are arrested, whereas in the B16 cells which continue to
proliferate c-myc expression is transiently increased. Subse-
quent Southern analyses of c-myc sequences did not indicate
any obvious alterations in the c-myc gene in the melanoma
cells as compared to normal spleen cells. Obviously, altera-
tions in this gene do not seem to be responsible for the
different responses of the respective cell lines to vera-
pamil. It remains to be established whether the different
levels of c-myc expression result from changed gene tran-
melanocytes and scription or changed mRNA stability, because it is possible
cell cycle transit. that verapamil affects post-transcriptional mechanisms that
verapamil, cells control the concentration of c-myc mRNA (Blanchard et al.,
,000 propidium 1985) differently in these cells. Post-transcriptional modula-
metry. G1 peaks tion of c-myc mRNA can be mediated by a labile degrada-
IR cells, and to tive protein and depends on active protein synthesis (Santos
cells. Triplicates et al., 1988). Inhibition of protein synthesis results in super-
induction of c-myc mRNA. Because verapamil stops protein
synthesis in cells that are arrested (Schmidt et al., 1988), our
data indicate that there is rather no post-transcriptional
modulation in the B10.BR cells as there is no superinduction
of c-myc mRNA. The B16 cells show a transient decline in
the number of cells entering into S-phase and a concomitant
synchronised progression of the cells that have been in S-
phase through the cell cycle. The transient increase in c-mvc
expression in this cell line induced by verapamil appears to
-c-myc be a consequence of the distribution of the cells in the
mitotic cycle because c-myc is expressed slightly higher in Gl
- 18S rRNA phase of the cell cycle, particularly after induction of differ- entiation (Lachman et al., 1985). After removal of verapamil
melanocytes and and extensive cell death there is also a decrease in the c-myc
on c-myc gene signal in the B16 cells.
cells were incu- Thus, we conclude that the changes in c-myc expression in
ated. Cells were B16 and B10.BR cells induced by verapamil are secondary to
ach resolved on other effects of the calcium channel blocker paralleling the
hybridised with distribution of cells in the cell cycle.
g) c-myc cDNA There is recent evidence that verapamil blocks Na+/H+
the same filters exchange in cultured cells thereby interfering with the
rolf 100%, 12h alkalinisation of the cytoplasm required for proliferation to
47%; BIO.BR: begin (Hunter et al., 1986; Bhalla & Sharma, 1986). In the
24h VP=42%, model of the signalling cascade that leads to DNA synthesis, alkalinisation of the cytoplasm occurs after increases in
cytoplasmic calcium concentration (Berridge, 1984). As we
have shown that verapamil seems to exert its effects indepen-
th this cell line dently of calcium fluxes (Schmidt et al., 1988), protein kinase
rain tumour cell C and c-myc expression, interference with cytoplasmic
al., 1988). In alkalinisation might be a likely candidate for verapamil's
cells have been antiproliferative effects. Work to test this possibility is
TPA. Thus, it currently underway in this laboratory.
sponses in cells
r results suggest This work was supported in part by ACS grant IN-107L and the
ct at some point South Carolina Endowment for Children's Cancer Research.
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